Showing results (1-10 of 11,939) with videos related to

Sort By:
Pageof 1,194
Harvard Business Review|February 8, 1992
The case of the hidden harassmentD Niven, C Wang, M P Rowe, et al.
Harvard Business Review|April 8, 1993
When times get tough, what happens to TQM? Case studyD Niven
Nihon Sanka Fujinka Gakkai Zasshi|August 1, 1992
[Role of growth factors in the regulation of embryo development and implantation]M Taga
Nihon Sanka Fujinka Gakkai Zasshi|June 1, 1982
[Studies on the intercompartmental relationship of PRL secretion during human pregnancy--maternal, fetal, and amniotic fluid PRL--(author's transl)]M Taga
Journal of Obstetrics and Gynaecology (Tokyo, Japan)|February 1, 1995
Practical management of postmenopausal women with low bone mineral densityM Taga
Medical Physics|May 16, 2006
Characterization of the phantom material virtual water in high-energy photon and electron beamsM R McEwen, D Niven
Chromosoma|October 1, 1994
Visualization of mitotic chromosomes in filamentous fungi by fluorescence staining and fluorescence in situ hybridizationM Taga, M Murata
European Journal of Endocrinology|August 1, 1997
Change in C-terminal cross-linking domain of type I collagen in urine, a new marker of bone resorption, during and after gonadotropin-releasing hormone agonist administrationM Taga, H Minaguchi
Talanta|September 1, 1989
Indirect atomic-absorption spectrophotometric determination of phosphorus after flotation as the ion-pair of molybdophosphate with bis[2-(5-chloro-2-pyridylazo)-5-diethylaminophenolato]cobalt(III)M Taga, M Kan
Acta Obstetricia Et Gynecologica Scandinavica|February 1, 1996
Reduction of bone mineral density by gonadotropin-releasing hormone agonist, nafarelin, is not completely reversible at 6 months after the cessation of administrationM Taga, H Minaguchi
Pageof 1,194